1 active not recruiting, 1 completed. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow bb1111: new trials by email Literature Review of bb1111 trials Research Report on bb1111
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease bb1111 - Sickle Cell Disease | Phase 3 | Active not recruiting | Genetix Biotherapeutics Inc. | 35 | 2020-02-14 | 2024-12-10 |
| A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease lovo-cel - Sickle Cell Disease | Phase 1 / Phase 2 | Completed | Genetix Biotherapeutics Inc. | 54 | 2015-02-02 | 2025-03-14 |
Genetix Biotherapeutics Inc. (2)
United States (2)
PMID 33811823, PMID 34115136, PMID 34898139, PMID 34922648, PMID 36161320, PMID 42133908